Back to Journals » OncoTargets and Therapy » Volume 8

The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies

Total article views   HTML views PDF downloads Totals
12,119 Dovepress* 11,297+ 1,655 12,952
PubMed Central* 822 178 1,000
Totals 12,119 1,833 13,952
*Since 8 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 1 11

View citations on PubMed Central and Google Scholar